| Trial Identifier: | D1843R00360 |
| Sponsor: | AstraZeneca |
| Start Date: | January 2024 |
| Primary Completion Date: | October 2025 |
| Study Completion Date: | October 2025 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
| Country | Location |
|---|---|
| Russia | Aramil, Russia |
| Russia | Chelyabinsk, Russia |
| Russia | Ekaterinburg, Russia |
| Russia | Irkutsk, Russia |
| Russia | Kaluga, Russia |
| Russia | Kazan, Russia |
| Russia | Kemerovo, Russia |
| Russia | Krasnodar, Russia |
| Russia | Krasnoyarsk, Russia |
| Russia | Moscow, Russia |
| Russia | Nizhniy Novgorod, Russia |
| Russia | Novosibirsk, Russia |
| Russia | Odintsovo, Russia |
| Russia | Omsk, Russia |
| Russia | Penza, Russia |
| Russia | Perm, Russia |
| Russia | Reutov, Russia |
| Russia | Rostov-on-Don, Russia |
| Russia | Ryazan, Russia |
| Russia | Saint-Petersburg, Russia |
| Russia | Samara, Russia |
| Russia | Stavropol, Russia |
| Russia | Tomsk, Russia |
| Russia | Tula, Russia |
| Russia | Ufa, Russia |
| Russia | Ulan-Ude, Russia |
| Russia | Volgograd, Russia |
| Russia | Vologda, Russia |
| Russia | Voronezh, Russia |
| Russia | Yaroslavl, Russia |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company